Carmen Coxon

Dr Coxon worked in academia for 15 years, specialising in drug discovery and drug repurposing in the area haemostasis and cancer, before joining the MHRA in 2017 as a research fellow. At the MHRA, Dr Coxon worked on the development of reference materials to standardise clinical tests used in the diagnosis and monitoring of antidrug antibodies in haemophilia A, before taking a secondment as a digital product manager during the COVID pandemic. She rejoined the Science Campus in 2023 to join ongoing efforts supporting research and innovation in the antimicrobial resistance space, going on to secure a 3-year grant from the Global Antimicrobial Resistance Innovation Fund (GAMRIF) to support R&I across One Health and with a lower- and middle-income country focus.